|
|
Article: Essential Therapeutics Announces Nasdaq Panel Hearing Date and Its Plans To Divest a Portion of Its California Operations.
- Article from:
- PR Newswire
- Article date:
- March 4, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Essential Therapeutics, Inc. today announced that a Nasdaq Listing Qualification Panel hearing date has been set for March 20, 2003, and the Company described its plans to divest of a portion of its California operations.
On January 31, 2003, the Company announced the receipt of a Nasdaq Staff determination letter indicating the Staff's decision to delist the Company's securities from The Nasdaq National Market due to the Company's failure to comply with the Nasdaq National Market System listing criteria which require the Company to maintain a minimum stockholders' equity of $10 million. The Company appealed the Staff's determination to the Nasdaq Listing ...